• Je něco špatně v tomto záznamu ?

Skin Doctor CP: Conformal Prediction of the Skin Sensitization Potential of Small Organic Molecules

A. Wilm, U. Norinder, MI. Agea, C. de Bruyn Kops, C. Stork, J. Kühnl, J. Kirchmair

. 2021 ; 34 (2) : 330-344. [pub] 20201209

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026071

Skin sensitization potential or potency is an important end point in the safety assessment of new chemicals and new chemical mixtures. Formerly, animal experiments such as the local lymph node assay (LLNA) were the main form of assessment. Today, however, the focus lies on the development of nonanimal testing approaches (i.e., in vitro and in chemico assays) and computational models. In this work, we investigate, based on publicly available LLNA data, the ability of aggregated, Mondrian conformal prediction classifiers to differentiate between non- sensitizing and sensitizing compounds as well as between two levels of skin sensitization potential (weak to moderate sensitizers, and strong to extreme sensitizers). The advantage of the conformal prediction framework over other modeling approaches is that it assigns compounds to activity classes only if a defined minimum level of confidence is reached for the individual predictions. This eliminates the need for applicability domain criteria that often are arbitrary in their nature and less flexible. Our new binary classifier, named Skin Doctor CP, differentiates nonsensitizers from sensitizers with a higher reliability-to-efficiency ratio than the corresponding nonconformal prediction workflow that we presented earlier. When tested on a set of 257 compounds at the significance levels of 0.10 and 0.30, the model reached an efficiency of 0.49 and 0.92, and an accuracy of 0.83 and 0.75, respectively. In addition, we developed a ternary classification workflow to differentiate nonsensitizers, weak to moderate sensitizers, and strong to extreme sensitizers. Although this model achieved satisfactory overall performance (accuracies of 0.90 and 0.73, and efficiencies of 0.42 and 0.90, at significance levels 0.10 and 0.30, respectively), it did not obtain satisfying class-wise results (at a significance level of 0.30, the validities obtained for nonsensitizers, weak to moderate sensitizers, and strong to extreme sensitizers were 0.70, 0.58, and 0.63, respectively). We argue that the model is, in consequence, unable to reliably identify strong to extreme sensitizers and suggest that other ternary models derived from the currently accessible LLNA data might suffer from the same problem. Skin Doctor CP is available via a public web service at https://nerdd.zbh.uni-hamburg.de/skinDoctorII/.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026071
003      
CZ-PrNML
005      
20211026133229.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.chemrestox.0c00253 $2 doi
035    __
$a (PubMed)33295759
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wilm, Anke $u Center for Bioinformatics (ZBH), Department of Informatics, Universität Hamburg, 20146 Hamburg, Germany $u HITeC e.V., 22527 Hamburg, Germany
245    10
$a Skin Doctor CP: Conformal Prediction of the Skin Sensitization Potential of Small Organic Molecules / $c A. Wilm, U. Norinder, MI. Agea, C. de Bruyn Kops, C. Stork, J. Kühnl, J. Kirchmair
520    9_
$a Skin sensitization potential or potency is an important end point in the safety assessment of new chemicals and new chemical mixtures. Formerly, animal experiments such as the local lymph node assay (LLNA) were the main form of assessment. Today, however, the focus lies on the development of nonanimal testing approaches (i.e., in vitro and in chemico assays) and computational models. In this work, we investigate, based on publicly available LLNA data, the ability of aggregated, Mondrian conformal prediction classifiers to differentiate between non- sensitizing and sensitizing compounds as well as between two levels of skin sensitization potential (weak to moderate sensitizers, and strong to extreme sensitizers). The advantage of the conformal prediction framework over other modeling approaches is that it assigns compounds to activity classes only if a defined minimum level of confidence is reached for the individual predictions. This eliminates the need for applicability domain criteria that often are arbitrary in their nature and less flexible. Our new binary classifier, named Skin Doctor CP, differentiates nonsensitizers from sensitizers with a higher reliability-to-efficiency ratio than the corresponding nonconformal prediction workflow that we presented earlier. When tested on a set of 257 compounds at the significance levels of 0.10 and 0.30, the model reached an efficiency of 0.49 and 0.92, and an accuracy of 0.83 and 0.75, respectively. In addition, we developed a ternary classification workflow to differentiate nonsensitizers, weak to moderate sensitizers, and strong to extreme sensitizers. Although this model achieved satisfactory overall performance (accuracies of 0.90 and 0.73, and efficiencies of 0.42 and 0.90, at significance levels 0.10 and 0.30, respectively), it did not obtain satisfying class-wise results (at a significance level of 0.30, the validities obtained for nonsensitizers, weak to moderate sensitizers, and strong to extreme sensitizers were 0.70, 0.58, and 0.63, respectively). We argue that the model is, in consequence, unable to reliably identify strong to extreme sensitizers and suggest that other ternary models derived from the currently accessible LLNA data might suffer from the same problem. Skin Doctor CP is available via a public web service at https://nerdd.zbh.uni-hamburg.de/skinDoctorII/.
650    _2
$a zvířata $7 D000818
650    _2
$a databáze faktografické $7 D016208
650    _2
$a test regionální lymfatické uzliny $7 D023441
650    _2
$a myši $7 D051379
650    _2
$a molekulární struktura $7 D015394
650    _2
$a organické látky $x chemie $x farmakologie $7 D009930
650    _2
$a kůže $x účinky léků $7 D012867
650    12
$a kožní testy $7 D012882
650    _2
$a knihovny malých molekul $x chemie $x farmakologie $7 D054852
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Norinder, Ulf $u Department of Computer and Systems Sciences, Stockholm University, SE-16407 Kista, Sweden $u Department of Pharmaceutical Biosciences, Uppsala University, SE-75124 Uppsala, Sweden $u MTM Research Centre, School of Science and Technology, Örebro University, SE-70182 Örebro, Sweden
700    1_
$a Agea, M Isabel $u Department of Informatics and Chemistry, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic
700    1_
$a de Bruyn Kops, Christina $u Center for Bioinformatics (ZBH), Department of Informatics, Universität Hamburg, 20146 Hamburg, Germany
700    1_
$a Stork, Conrad $u Center for Bioinformatics (ZBH), Department of Informatics, Universität Hamburg, 20146 Hamburg, Germany
700    1_
$a Kühnl, Jochen $u Front End Innovation, Beiersdorf AG, 22529 Hamburg, Germany
700    1_
$a Kirchmair, Johannes $u Center for Bioinformatics (ZBH), Department of Informatics, Universität Hamburg, 20146 Hamburg, Germany $u Department of Pharmaceutical Chemistry, University of Vienna, 1090 Vienna, Austria
773    0_
$w MED00002106 $t Chemical research in toxicology $x 1520-5010 $g Roč. 34, č. 2 (2021), s. 330-344
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33295759 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133235 $b ABA008
999    __
$a ok $b bmc $g 1714936 $s 1146578
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 34 $c 2 $d 330-344 $e 20201209 $i 1520-5010 $m Chemical research in toxicology $n Chem Res Toxicol $x MED00002106
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...